Results 161 to 170 of about 13,217 (287)

Biphosphonates-related osteonecrosis of the jaw: multicenter study

, 2012
Biphosphonates-related osteonecrosis of the jaw is defined as an exposure of necrotic bone in maxillofacial region,which persists more than 8 weeks in patients treated or,in course of treatment whit biphosphonate, not been subjected to radiation therapy ...
GARAU, VALENTINO, DENOTTI, GLORIA, PIRAS, VINCENZO, Brunelli G, Marini M, Orani L, Brugnati C, Carinci F, Piras A   +8 more
core  

Preparing Dental Hygiene Students to Care for Patients With Breast Cancer

Journal of Dental Education, Volume 90, Issue S1, Page S6-S7, June 2026.
Denise M. Messina, Matthew J. Messina
wiley   +1 more source

Concurrent Osteonecrosis of the Jaw and Hip in a Child With Severe Aplastic Anemia Undergoing Transplant

We present the first case of concomitant hip and jaw osteonecrosis in a 10-year-old child with aplastic anemia undergoing a transplant. Biphosphonate treatment may be beneficial for hip osteonecrosis but harmful for jaw osteonecrosis.
TOPUZ TÜRKCAN, BÜŞRA, KİRKİZ KAYALI, SERAP, KAYA, ZÜHRE, YILMAZ, METİN, KOÇAK, ÜLKER, Boyunaga, ÖZNUR LEMAN   +5 more
core   +1 more source

Bisphosphonates and Osteonecrosis of the Jaw [PDF]

Mayo Clinic Proceedings, 2017
openaire   +2 more sources

Proteome and miRNAs Expression in Medication-Related Osteonecrosis of the Jaw. [PDF]

Int J Mol Sci
Allegra A, De Salvo R, Marcianò A, Polito F, Stagno F, Carleo A, Costanzo M, Caterino M, Ragusa M, Licitri L, Drago SFA, Gasparo I, Alberti G, Khouyyi M, Siniscalchi EN, Oteri G, Bini L, Macaione V, Bianchi L, Aguennouz M.   +19 more
europepmc   +1 more source

Vitamin D Deficiency as a Context-Dependent Modifier of Osteonecrosis of the Jaw. [PDF]

Nutrients
Lu CL, Huang RY, Zheng CM, Lu KC.
europepmc   +1 more source

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer. [PDF]

BJUI Compass
Tani M, Hatano K, Kamiya T, Konishi M, Matsukawa A, Horitani H, Inoguchi S, Kanaki T, Yoshimura A, Horibe Y, Liu Y, Sassi N, Oka T, Okuda Y, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Watabe T, Kawashima A, Isohashi K, Nonomura N.   +22 more
europepmc   +1 more source

Medication-related osteonecrosis of the jaw : occurence, risk factors, pathogenesis & treatment

, 2019
The antiresorptive drugs bisphosphonates and denosumab are widely used to preserve bone strength by inhibiting osteoclast mediated bone resorption. High dose intravenous bisphosphonates and high dose denosumab are mainly used to treat skeletal related
Hallmer, Fredrik
core  

Postoperative healing and recurrence in osteonecrosis of the jaw: influence of risk factors and surgical approach. [PDF]

Clin Oral Investig
Mohr J, Pippich K, Cherdron C, Ketschau J, Erben P, Kram H, Krautkremer N, Deppe H, Wolff KD, Ritschl LM.   +9 more
europepmc   +1 more source

Medication-related osteonecrosis of the jaw in an adult with osteogenesis imperfecta: a case report. [PDF]

Front Oral Health
Zhu WY, Wan W, Wu PA, Zhou LW.
europepmc   +1 more source